11 Einträge gefunden

1. Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy

   1. Chari, Ajai
   2. Munder, Markus
   3. Weisel, Katja
   4. Jenner, Matthew
   5. Bygrave, Ceri
   6. Petrucci, Maria Teresa
   7. Boccadoro, Mario

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

   1. Ludwig, Heinz
   2. Boccadoro, Mario
   3. Moreau, Philippe
   4. San-Miguel, Jesus
   5. Cavo, Michele
   6. Pawlyn, Charlotte
   7. Zweegman, Sonja

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Ixazomib-lenalidomide-dexamethasone in routine clinical practice:effectiveness in relapsed/refractory multiple myeloma

   1. Hájek, Roman
   2. Minařík, Jiří
   3. Straub, Jan
   4. Pour, Luděk
   5. Jungova, Alexandra
   6. Berdeja, Jesus G
   7. Boccadoro, Mario

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Gascón, Pere
   3. Bokemeyer, Carsten
   4. Aapro, Matti
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
5. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Bokemeyer, Carsten
   3. Aapro, Matti
   4. Boccadoro, Mario
   5. Gascón, Pere
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
6. Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study

   1. Bokemeyer, Carsten
   2. Gascón, Pere
   3. Aapro, Matti
   4. Ludwig, Heinz
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2017 - Forschungsinformationssystem des UKE
7. Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)

   1. Aapro, Matti
   2. Bokemeyer, Carsten
   3. Ludwig, Heinz
   4. Gascón, Pere
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2016 - Forschungsinformationssystem des UKE
8. Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

   1. Gascón, Pere
   2. Aapro, Matti
   3. Ludwig, Heinz
   4. Bokemeyer, Carsten
   5. Boccadoro, Mario
   6. Turner, Matthew
   7. Denhaerynck, Kris

   2016 - Forschungsinformationssystem des UKE
9. Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

   1. Gascón, Pere
   2. Aapro, Matti
   3. Ludwig, Heinz
   4. Bokemeyer, Carsten
   5. Boccadoro, Mario
   6. Turner, Matthew
   7. Denhaerynck, Kris

   2015 - Forschungsinformationssystem des UKE
10. How to manage neutropenia in multiple myeloma.

    1. Palumbo, Antonio
    2. Bladé, Jon
    3. Boccadoro, Mario
    4. Palladino, Carmela
    5. Davies, Faith
    6. Dimopoulos, Meletios
    7. Dmoszynska, Anna

    2012 - Forschungsinformationssystem des UKE
11. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

    1. Palumbo, Antonio
    2. Bringhen, Sara
    3. Ludwig, Heinz
    4. Dimopoulos, Meletios A
    5. Bladé, Joan
    6. Mateos, Maria V
    7. Rosiñol, Laura

    2011 - Forschungsinformationssystem des UKE